Immix Biopharma (IMMX) Shares Outstanding (2020 - 2026)

Immix Biopharma has disclosed Shares Outstanding across 7 years of filings, most recently posting $53.1 million for Q1 2026.

• Shares Outstanding for Q1 2026 came in at $53.1 million, up 90.1% year-over-year; the trailing twelve-month figure through Mar 2026 was $53.1 million (up 90.1% YoY), and the FY2025 annual result was $53.0 million, up 92.03% from the prior year.
• Shares Outstanding came in at $53.1 million for Q1 2026 at Immix Biopharma, roughly flat from $53.0 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $53.0 million in Q4 2025 to a low of -$37418.0 in Q2 2022.
• The 5-year median for Shares Outstanding is $26.5 million (2024), against an average of $24.5 million.
• Across the five-year window, Shares Outstanding sank 100.52% in 2023 and surged 38105.0% in 2024, its largest moves.
• Immix Biopharma's Shares Outstanding stood at $14.0 million in 2022, then surged by 43.18% to $20.0 million in 2023, then surged by 38.1% to $27.6 million in 2024, then jumped by 92.03% to $53.0 million in 2025, then increased by 0.12% to $53.1 million in 2026.
• The last three Shares Outstanding figures came in at $53.1 million (Q1 2026), $53.0 million (Q4 2025), and $33.1 million (Q3 2025), per Business Quant data.